We provide innovative medical propellants to the world’s biggest pharmaceutical companies. All of our products are produced to the most demanding industry standards at our dedicated facilities. Find out more about our global community.
Zephex® 152a will reduce the carbon footprint by 90% compared to current metered dose inhalers. Our low GWP medical propellant is a commitment to both end users and our environment.
From the Newsroom
We interviewed Dr. Tim Noakes, Koura’s Technical Associate, who has had a fundamental role in the creation of the HFA medical propellant business for ICIRead more
The University of Manchester has announced Jack Fearon as the fourth student to receive Koura’s Alasdair Sinclair Scholarship. The scholarship was set up in 2017Read more